Thus, a combination of REG4 with CA125 and HE4 could provide a more comprehensive marker panel for preoperative diagnosis of potentially neoplastic ovarian masses, and enable distinction of mucinous ovarian cancer from other ovarian cancer histotypes. This evidence concerns the gene REG4 and ovarian cancer.